Augmentation of peripheral lymphocyte-derived cholinergic activity in patients with acute ischemic stroke
Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible a...
Saved in:
| Published in | BMC neurology Vol. 19; no. 1; pp. 236 - 9 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
15.10.2019
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2377 1471-2377 |
| DOI | 10.1186/s12883-019-1481-5 |
Cover
| Abstract | Background
Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality.
Methods
In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes.
Results
Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (
r
= 0.67,
P
< 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/10
6
PBMC versus 0.15 ± 0.01 ng/10
6
PBMC,
P
= 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke.
Conclusions
Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. |
|---|---|
| AbstractList | Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality. In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes. Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 [+ or -] 0.02 ng/10.sup.6 PBMC versus 0.15 [+ or -] 0.01 ng/10.sup.6 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke. Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality. Methods In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes. Results Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/106 PBMC versus 0.15 ± 0.01 ng/106 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke. Conclusions Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality. Methods In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes. Results Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume ( r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/10 6 PBMC versus 0.15 ± 0.01 ng/10 6 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke. Conclusions Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Abstract Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality. Methods In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes. Results Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/106 PBMC versus 0.15 ± 0.01 ng/106 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke. Conclusions Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality.BACKGROUNDBrain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality.In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes.METHODSIn this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes.Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/106 PBMC versus 0.15 ± 0.01 ng/106 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke.RESULTSWithin 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/106 PBMC versus 0.15 ± 0.01 ng/106 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke.Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection.CONCLUSIONSLymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality. In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes. Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 ± 0.02 ng/10 PBMC versus 0.15 ± 0.01 ng/10 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke. Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the cholinergic pathway impacts immune defenses and disease outcomes in patients with ischemic stroke. This study investigated a possible association between peripheral cholinergic activity, post-stroke infection, and mortality. Methods In this study, we enrolled 458 patients with acute ischemic stroke (< 24 h after onset), 320 patients with ischemic stroke on day 10, and 216 healthy subjects. Peripheral cholinergic activity, reflected by intracellular acetylcholine (ACh) content in human peripheral blood mononuclear cells (PBMCs), was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Expression of acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) was measured by quantitative real-time PCR and western blot. Regression analyses were used to assess associations between peripheral cholinergic function and clinical outcomes. Results Within 24 h after the onset of acute ischemic stroke, there was a rapid increase in peripheral cholinergic activity that correlated with brain infarction volume (r = 0.67, P < 0.01). Specifically, lymphocyte-derived ACh levels were significantly higher in stroke patients with pneumonia (0.21 [+ or -] 0.02 ng/10.sup.6 PBMC versus 0.15 [+ or -] 0.01 ng/10.sup.6 PBMC, P = 0.03). Of note, lymphocytic AChE catalytic activity was significantly lower in these patients. One-year mortality was significantly greater in patients with higher intracellular ACh levels within the first 24 h after acute stroke. Conclusions Lymphocytes produced increased amounts of ACh in patients with acute stroke, and pneumonia was a likely result. The association between this enhanced cholinergic activity and increased risk of pneumonia/mortality suggests that increased cholinergic activity may contribute to fatal post-stroke infection. Keywords: Ischemic stroke, Acetylcholine, Inflammation |
| ArticleNumber | 236 |
| Audience | Academic |
| Author | Wang, Chunyang Liu, Ye Yuan, Meng Zhang, Chao Xia, Yiping Han, Bin |
| Author_xml | – sequence: 1 givenname: Meng surname: Yuan fullname: Yuan, Meng organization: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital – sequence: 2 givenname: Bin surname: Han fullname: Han, Bin organization: Department of Neurology, The Affiliated Hospital of Qingdao University – sequence: 3 givenname: Yiping surname: Xia fullname: Xia, Yiping organization: Laboratory of Physical and Chemical Research, Tianjin Centers for Disease Control and Prevention – sequence: 4 givenname: Ye surname: Liu fullname: Liu, Ye organization: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital – sequence: 5 givenname: Chunyang surname: Wang fullname: Wang, Chunyang organization: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital – sequence: 6 givenname: Chao orcidid: 0000-0002-0659-4597 surname: Zhang fullname: Zhang, Chao email: chaozhang@tmu.edu.cn organization: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31615442$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1v1DAQjVARbRd-ABcUiQuXlPgjsXNBqio-KlXi0rvl2JPESxIHO1m0_57ZprTdClAOjmbee-M3fufJyehHSJK3JL8gRJYfI6FSsiwnVUa4JFnxIjkjXJCMMiFOnvyfJucxbvOcCMnJq-SUkZIUnNOzxF0u7QDjrGfnx9Q36QTBTR0E3af9fpg6b_YzZBarO7Cp6XzvRgitM6k2s9u5eZ-6MZ2Qjyox_eXmDjvLDKmLpoMBgXEO_ge8Tl42uo_w5v7cJLdfPt9efctuvn-9vrq8yUyZszmrJGugtpLlteS1bSjXLGdSiJLUlaENFJwS0RRVCUQWkplaYjNvCmMbi7RNcr3KWq-3agpu0GGvvHbqruBDq3SYnelBMV1yJlDBVpYTRmvNGQEKWlNqBU7dJJ9WrWmpB7AGHeJejkSPO6PrVOt3qhQVpUWBAh_uBYL_uUCc1YBbgb7XI_glKsrykhJ0RxH6_hl065cw4qbuUJKVhLJHVKvRgBsbj3PNQVRdljmVrCoYR9TFX1D42cN7YIYah_UjwrunRh8c_skJAsgKMMHHGKB5gJBcHbKo1iwqzKI6ZFEdzItnHOPWnOFtXP9fJl2ZEaeMLYTHXfyb9BsgvPLD |
| CitedBy_id | crossref_primary_10_3390_neurolint15020042 crossref_primary_10_7759_cureus_15055 crossref_primary_10_12677_ACM_2023_13112544 crossref_primary_10_1007_s00210_022_02346_9 crossref_primary_10_1016_j_brainres_2020_147196 crossref_primary_10_1111_jnc_15169 crossref_primary_10_1016_j_bcp_2021_114768 crossref_primary_10_3389_fimmu_2021_660342 |
| Cites_doi | 10.1038/ni1078 10.1111/bph.12247 10.1161/STROKEAHA.115.008989 10.1007/s00216-011-4940-4 10.1002/cphy.c140016 10.1038/ncomms13202 10.1016/j.jchromb.2016.04.024 10.1007/s00109-007-0226-x 10.1161/01.STR.0000258346.68966.9d 10.1016/j.brainres.2009.10.076 10.1126/science.1209985 10.1186/1742-2094-9-24 10.2741/1390 10.1016/j.coph.2017.12.003 10.1073/pnas.1221655110 10.3945/ajcn.110.005413 10.1053/jscd.2003.7 10.1371/journal.pone.0120441 10.1038/jcbfm.2008.140 10.1016/j.neulet.2009.05.018 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2019 COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s). 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12883-019-1481-5 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2377 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_3a64373cbd9d4132ba431e2eaa22d730 PMC6792255 A602839534 31615442 10_1186_s12883_019_1481_5 |
| Genre | Journal Article |
| GeographicLocations | United States--US Germany |
| GeographicLocations_xml | – name: United States--US – name: Germany |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81601019; 81601039 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: National Natural Science Foundation of China grantid: 81601019 – fundername: National Natural Science Foundation of China grantid: 81601039 – fundername: ; grantid: 81601019; 81601039 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM PMFND 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c603t-983febd830b84bdf24a30387761b9c2fe54217f596e18583cb88770f5cdfdd83 |
| IEDL.DBID | M48 |
| ISSN | 1471-2377 |
| IngestDate | Wed Aug 27 01:32:11 EDT 2025 Tue Sep 30 16:04:08 EDT 2025 Thu Sep 04 23:52:19 EDT 2025 Fri Jul 25 04:56:31 EDT 2025 Tue Jun 17 21:12:10 EDT 2025 Tue Jun 10 20:16:48 EDT 2025 Thu Jan 02 22:59:45 EST 2025 Wed Oct 01 00:53:44 EDT 2025 Thu Apr 24 23:07:14 EDT 2025 Sat Sep 06 07:35:58 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Acetylcholine Inflammation Ischemic stroke |
| Language | English |
| License | Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c603t-983febd830b84bdf24a30387761b9c2fe54217f596e18583cb88770f5cdfdd83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0659-4597 |
| OpenAccessLink | https://www.proquest.com/docview/2306836123?pq-origsite=%requestingapplication% |
| PMID | 31615442 |
| PQID | 2306836123 |
| PQPubID | 44772 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3a64373cbd9d4132ba431e2eaa22d730 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6792255 proquest_miscellaneous_2306213872 proquest_journals_2306836123 gale_infotracmisc_A602839534 gale_infotracacademiconefile_A602839534 pubmed_primary_31615442 crossref_primary_10_1186_s12883_019_1481_5 crossref_citationtrail_10_1186_s12883_019_1481_5 springer_journals_10_1186_s12883_019_1481_5 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-10-15 |
| PublicationDateYYYYMMDD | 2019-10-15 |
| PublicationDate_xml | – month: 10 year: 2019 text: 2019-10-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC neurology |
| PublicationTitleAbbrev | BMC Neurol |
| PublicationTitleAlternate | BMC Neurol |
| PublicationYear | 2019 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | E Ben Assayag (1481_CR17) 2010; 16 M Yamada (1481_CR6) 2018; 40 SM Innis (1481_CR12) 2011; 93 M Rosas-Ballina (1481_CR8) 2011; 334 Q Wang (1481_CR2) 2012; 9 L Galle-Treger (1481_CR5) 2016; 18 A Chamorro (1481_CR4) 2007; 38 O Engel (1481_CR7) 2015; 46 NM Pinheiro (1481_CR18) 2015; 10 BI Kalappa (1481_CR21) 2013; 169 ST Lee (1481_CR19) 2010; 1309 I Ay (1481_CR1) 2009; 459 A Ottani (1481_CR20) 2009; 29 AM Dorrance (1481_CR3) 2015; 5 K Ofek (1481_CR14) 2007; 85 L Steinman (1481_CR15) 2004; 5 C Reardon (1481_CR9) 2013; 110 C Zhang (1481_CR10) 2016; 1022 K Kawashima (1481_CR16) 2004; 9 SJ Pittock (1481_CR11) 2003; 12 G McRae (1481_CR13) 2011; 400 |
| References_xml | – volume: 5 start-page: 575 year: 2004 ident: 1481_CR15 publication-title: Nat Immunol doi: 10.1038/ni1078 – volume: 169 start-page: 1862 year: 2013 ident: 1481_CR21 publication-title: Br J Pharmacol doi: 10.1111/bph.12247 – volume: 46 start-page: 3232 year: 2015 ident: 1481_CR7 publication-title: Stroke. doi: 10.1161/STROKEAHA.115.008989 – volume: 400 start-page: 2205 year: 2011 ident: 1481_CR13 publication-title: Anal Bioanal Chem doi: 10.1007/s00216-011-4940-4 – volume: 5 start-page: 1241 year: 2015 ident: 1481_CR3 publication-title: Comprehensive Physiology doi: 10.1002/cphy.c140016 – volume: 18 start-page: 13202 issue: 7 year: 2016 ident: 1481_CR5 publication-title: Nat Commun doi: 10.1038/ncomms13202 – volume: 1022 start-page: 265 year: 2016 ident: 1481_CR10 publication-title: Analyt Technol Biomed Life Sci doi: 10.1016/j.jchromb.2016.04.024 – volume: 85 start-page: 1239 year: 2007 ident: 1481_CR14 publication-title: J Mol Med (Berlin, Germany) doi: 10.1007/s00109-007-0226-x – volume: 38 start-page: 1097 year: 2007 ident: 1481_CR4 publication-title: Stroke. doi: 10.1161/01.STR.0000258346.68966.9d – volume: 1309 start-page: 164 year: 2010 ident: 1481_CR19 publication-title: Brain Res doi: 10.1016/j.brainres.2009.10.076 – volume: 334 start-page: 98 year: 2011 ident: 1481_CR8 publication-title: Science (New York, N.Y.) doi: 10.1126/science.1209985 – volume: 9 start-page: 24 year: 2012 ident: 1481_CR2 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-9-24 – volume: 9 start-page: 2063 year: 2004 ident: 1481_CR16 publication-title: Front Biosci doi: 10.2741/1390 – volume: 40 start-page: 18 year: 2018 ident: 1481_CR6 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2017.12.003 – volume: 110 start-page: 1410 year: 2013 ident: 1481_CR9 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1221655110 – volume: 93 start-page: 564 year: 2011 ident: 1481_CR12 publication-title: Am J Clin Nutr doi: 10.3945/ajcn.110.005413 – volume: 16 start-page: 278 year: 2010 ident: 1481_CR17 publication-title: Mol Med (Cambridge, Mass.) – volume: 12 start-page: 1 year: 2003 ident: 1481_CR11 publication-title: J Stroke Cerebrovasc Dis doi: 10.1053/jscd.2003.7 – volume: 10 year: 2015 ident: 1481_CR18 publication-title: PLoS One doi: 10.1371/journal.pone.0120441 – volume: 29 start-page: 512 year: 2009 ident: 1481_CR20 publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.2008.140 – volume: 459 start-page: 147 year: 2009 ident: 1481_CR1 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2009.05.018 |
| SSID | ssj0017841 |
| Score | 2.2848818 |
| Snippet | Background
Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation... Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation of the... Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether activation... Abstract Background Brain ischemia activates the parasympathetic cholinergic pathway in animal models of human disease. However, it remains unknown whether... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 236 |
| SubjectTerms | Acetylcholine Acetylcholine - immunology Acetylcholine - metabolism Acetylcholinesterase Acetyltransferase Aged Animal models Brain infarction Brain Ischemia - immunology Brain Ischemia - metabolism Brain research Cerebral infarction Cerebrovascular disease and stroke Choline Choline O-acetyltransferase Chromatography Drug therapy Female Hospitals Humans Infection Infections Inflammation Intracellular Ischemia Ischemic stroke Leukocytes (mononuclear) Liquid chromatography Lymphocytes Lymphocytes - immunology Lymphocytes - metabolism Male Mass spectrometry Mass spectroscopy Medical research Medicine Medicine & Public Health Middle Aged Mortality Nervous system Neurochemistry Neurology Neurosurgery Parasympathetic nervous system Patient outcomes Peripheral blood mononuclear cells Pneumonia Research Article Risk factors Scientific imaging Spectroscopy Stroke Stroke patients Studies |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifltdJYIgKGGbrzY9PsVlEdbTCnsLzZcWn63s6xP2v3emzXtuV9SL104CycxkPjrJbwh5WSauuHOR6ZoHpmIqWVt5zWqD2lVWPk6gPqcfq5NP6sO5Pr_S6gvvhM3wwDPjjmSLpSXpXWgCGFzhWnB5UcS2FSKAeqL1BTe2S6Zy_QCrabmGyU11tOHYVBfS5oZB-M-ZXnihCaz_d5N8xSddvy95rWg6-aLjO-R2DiLpal78XXIj9vfIzdNcJr9PutX287f8qKinQ6IIZzzhB6zp-hLkN_jLMbIAX3_EQNECTm8AO0_xnQO2k6BdTzPm6obiz1qgbMdIO8iG8T493YwXw9f4gJwdvz97d8JyTwXmq1KOrDEyRReMLJ1RLiShWokV7LrirvEiRa0gSUm6qSJ4cgN8BytUl0n7kAJMe0gO-qGPjwlNEigQnYmaJ1WX3kjlGqMgvIGYArK4gpQ7Fluf8cax7cXaTnmHqewsFQtSsSgVqwvyej_l-wy28bfBb1Fu-4GIkz19AO2xWXvsv7SnIK9Q6hZPMyzOt_lRAmwRcbHsqsL4q9FSFeRwMRJOoV-Sd3pjsxXYWEzvjESAm4K82JNxJt5s6-OwnccIDhIQBXk0q9l-SxLDcaWAUi8UcLHnJaXvvkwY4VXdgKUGJr3ZqeqvZf2RpU_-B0ufkltiOmgl4_qQHIwX2_gMArfRPZ_O6E-1YD02 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9UwFA86QXwRv-2cEkEQlLCmSdP2Sa7iGMJ8mnDfQpuPedm1nbe9g_33npPmdnbiXnsSaHK-c5LfIeRd6rnkTeNYXnDLpPMpq5XJWVGidKXKuADqc_JdHf-Q35b5Mh649fFa5c4mBkNtO4Nn5IcYKpcCwUI-Xfxm2DUKq6uxhcZdco9DqIJSXSynhItjTS1WMnmpDnuOrXUhea4YJAGc5TNfFCD7_zXMf3mmm7cmb5ROg0c6ekQexlCSLkbePyZ3XPuE3D-JxfKnZLXYnv2KT4ta2nmKoMYBRWBN11fAxc5cDY5Z-HrpLEU7GF4CrgzF1w7YVIKuWhqRV3uKR7ZA2Q6OriAnxlv1tB823bl7Rk6Pvp5-OWaxswIzKhUDq0rhXWNLkTalbKzPZC2wjl0o3lQm8y6XkKr4vFIO_HkpTAO2qEh9bqy3MO052Wu71r0k1AugQIyWFdzLIjWlkE1VSghyILKAXC4h6W6LtYmo49j8Yq1D9lEqPXJFA1c0ckXnCfkwTbkYITduG_wZ-TYNRLTs8KHbnOmofFrUWJ6EVdjKgtPOmhrCJpe5us4yCyYuIe-R6xp1Gn7O1PFpAiwR0bH0QmEUVuVCJuRgNhJ00czJO7nR0Rb0-lpyE_J2IuNMvN_Wum47jsk4cCBLyItRzKYlCQzKpQRKMRPA2ZrnlHb1MyCFq6ICew2b9HEnqte_9d8t3b99Ea_IgyyoUMp4fkD2hs3WvYbAbGjeBO37A-lGNMc priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFA66gvgi3q2uEkEQlGCbW9vHcXBZhPVphX0LbS5aHFvZ6Qj77z0nzdTtegFfexJIcu49OV8IeZmHQhZt65kqC8ekDzlrtFWsrFC6cm19BPU5-aiPP8kPZ-osgUVjL8zl-n1R6bfbAp_DhYS3ZhC4F0xdJzcU2F28vbfW67lggOWzVLT847SF24no_L_b4EtO6OoFyStV0uh8ju6Q2ylqpKuJzXfJNd_fIzdPUl38PulWu8_fUhdRT4dAEb84AgZs6OYCGDbYi9EzB19_eEfR5MWmv85SbGzA9yNo19MEsrql-HcWKLvR0w7SX7xAT7fj-fDVPyCnR-9P18csPaLArM7FyOpKBN-6SuRtJVsXuGwElqxLXbS15cErCVlJULX24LorYVswO2UelHXBwbSH5KAfev-Y0CCAAuEYL4sgy9xWQrZ1JSGegSAC0raM5PsjNjYBjOM7FxsTE41Km4krBrhikCtGZeT1POX7hK7xr8HvkG_zQATGjh9AXkzSMyMarETCLlztwD_ztoEIyXPfNJw7sGYZeYVcN6i-sDjbpC4E2CICYZmVxoCrVkJm5HAxEtTOLsl7uTFJ7bcG87lKIKJNRl7MZJyJV9l6P-ymMbwADvCMPJrEbN6SwPhbSqCUCwFc7HlJ6bsvERRclzWYZjikN3tR_bWsvx7pk_8a_ZTc4lGjclaoQ3Iwnu_8MwjJxvZ5VMafFWotVQ priority: 102 providerName: Springer Nature |
| Title | Augmentation of peripheral lymphocyte-derived cholinergic activity in patients with acute ischemic stroke |
| URI | https://link.springer.com/article/10.1186/s12883-019-1481-5 https://www.ncbi.nlm.nih.gov/pubmed/31615442 https://www.proquest.com/docview/2306836123 https://www.proquest.com/docview/2306213872 https://pubmed.ncbi.nlm.nih.gov/PMC6792255 https://doaj.org/article/3a64373cbd9d4132ba431e2eaa22d730 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central_OA刊 customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: ABDBF dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals - Free Access to All customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1471-2377 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: M48 dateStart: 20010101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1471-2377 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017841 issn: 1471-2377 databaseCode: C6C dateStart: 20011201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELf2ISFeEN8ERmUkBBLIkNhOnDwg1FWbJqROCG3S3qzEsUdFSbY2RfS_5851OzIG4rE5u4rvw3eXs39HyMvYJTKpKstSldRMWhezMjMpUzlqV5wZ60F9xsfZ0an8dJaebZF19TwwcH5jaof9pE5n03c_L5cfweA_eIPPs_fzBFvmQlJcMAjuE5a-urhk2FcK66-hycY22QVfxVHvx_KqzoBVN3__SCWMC6VC3fPGf-15Lg_w_-c2_psfu37G8lqh1fuvw7vkTgg86XClKffIlm3uk1vjUFp_QCbDxfn3cBGpoa2jCIHsMQemdLoEmbdm2VlWw9MftqbIOH9vcGIo3o3AFhR00tCA0zqn-IEXKIvO0gmwGc_g03k3a7_Zh-Tk8OBkdMRCHwZmslh0rMiFs1Wdi7jKZVU7LkuBVW-VJVVhuLOphMTGpUVmwfvnwlSwc6nYpaZ2NUx7RHaatrFPCHUCKBDRcZU4qWKTC1kVuYSQCOIQyPwiEq9ZrE3AKMdWGVPtc5U80yupaJCKRqnoNCJvNlMuVgAd_xq8j3LbDERsbf-gnZ3rYKpalFjMhFXURQ0unlclBFmW27LkvIYNMSKvUeoadRJezpThIgMsEbG09DDDmK1IhYzIXm8kWK7pk9d6o9eKrzElzAWC4kTkxYaMM_E0XGPbxWoMT0ACPCKPV2q2WZLAEF5KoKieAvbW3Kc0k68eVzxTBezuwKS3a1W9eq2_svTpf7zlM3KbezuKWZLukZ1utrDPIZbrqgHZVmdqQHb3D44_f4Ffo2w08N9FBt5QfwFVGUeT |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4k2ggJFASCCrie28Dggtj2pLuz0tUm9W4kdZsSRlNwvaH8V_ZMZJtqSI3nrN2FHseWfsbwh5EbpIRmVpWZxGhknrQlYkOmZphtIVJtp6UJ_JUTL-Ij8fx8db5Hd_FwaPVfY20RtqU2v8R76LoXImECzk3ekPhl2jsLrat9BoxeLArn9ByrZ8u_8R-PuS871P0w9j1nUVYDoJRcPyTDhbmkyEZSZL47gsBNZwIZ8vc82djSWE6S7OEwu-LBO6BD1MQxdr4wxMg9deIVelCCVC9afHm_wuwhJeVziNsmR3GWEnX8jVcwY5R8TigevzHQL-9QN_OcLzhzTPVWq9A9y7RW52kSsdtaJ2m2zZ6g65Nulq83fJbLQ6-d7dZKpo7ShiKHvQgjmdr0Foar1uLDPw9Kc1FM2uv3g40xQvV2APCzqraAf0uqT4hxgoq8bSGaTgeIifLptF_c3eI9PL2PL7ZLuqK_uQUCeAAiEhTyMn01BnQpZ5JiGmgkAGUseAhP0WK92BnGOvjbnyyU6WqJYrCriikCsqDsjrzZTTFuHjosHvkW-bgQjO7R_UixPV6boSBVZDYRUmNxAj8LKAKM1yWxScG7CoAXmFXFdoQuDjdNHdhIAlIhiXGiUY9OWxkAHZGYwE1ddDci83qjM9S3WmKAF5viHjTDxOV9l61Y7hEXCAB-RBK2abJQnMAaQESjoQwMGah5Rq9tUDkydpDu4BNulNL6pnn_XfLX108SKekevj6eRQHe4fHTwmN7hXp5BF8Q7ZbhYr-wRiwqZ86jWREnXJmv8HAjZw4Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ra9UwFA-6wfCL-LY6NYIgKGFtk7bpx_q4zKsbghP2LbR5zOK1Hbe9wv57z2lzq50P8GtPAknOuyf5HUKehS4SUVVZlmSRYcK6kJWpTlgmUbrCVNsB1OfoOD38LJanyanvc9ptb7tvS5LjmwZEaWr6g3PjRhWX6UEXYZNcSINzBuF8xJKrZFcmeQrZ125RLD8tp0ICltV8MfOPE2fuaEDt_902_-KcLl-cvFQ9HZzS4ga57qNJWozsv0mu2OYW2Tvy9fLbpC42Z9_866KGto4irvEAJLCiqwtgZKsvessMfP1uDUVTODwGrDXFBw_YV4LWDfXgqx3Fv7ZA2fSW1pAW48V62vXr9qu9Q04Wb09eHzLfXIHpNOQ9yyV3tjKSh5UUlXGxKDmWsrM0qnIdO5sIyFYcHKoFly65rsAcZaFLtHEGpt0lO03b2PuEOg4UCNPiLHIiC7XkosqlgDgHggtI5wISbo9YaQ88jv0vVmpIQGSqRq4o4IpCrqgkIC-mKecj6sa_Br9Cvk0DETB7-NCuz5TXP8VLrFDCLkxuwG_HVQmRk41tWcaxASsXkOfIdYVqDYvTpX-dAFtEgCxVpBiI5QkXAdmfjQR11HPyVm6UNwedwjxPckS6CcjTiYwz8YpbY9vNOCaOgANxQO6NYjZtiWNcLgRQspkAzvY8pzT1lwEsPM1yMNlwSC-3ovpzWX890gf_NfoJ2fv4ZqE-vDt-_5BciwflClmU7JOdfr2xjyBq66vHXjN_AAwZOgA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Augmentation+of+peripheral+lymphocyte-derived+cholinergic+activity+in+patients+with+acute+ischemic+stroke&rft.jtitle=BMC+neurology&rft.au=Yuan%2C+Meng&rft.au=Han%2C+Bin&rft.au=Xia%2C+Yiping&rft.au=Liu%2C+Ye&rft.date=2019-10-15&rft.issn=1471-2377&rft.eissn=1471-2377&rft.volume=19&rft.issue=1&rft.spage=236&rft_id=info:doi/10.1186%2Fs12883-019-1481-5&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon |